Prospective evaluation of simply modified MODS assay: An effective tool for TB diagnosis and detection of MDR-TB

Infection and Drug Resistance

Volumn 5, Issue 1, 2012, Pages 79-86

  Chaiyasirinroje, Boonchai ^a   Aung, Myo Nyein ^b,c   Moolphate, Saiyud ^a,d   Kasetjaroen, Yuthichai ^e   Rienthong, Somsak ^e   Rienthong, Dhanida ^e   Nampaisan, Oranuch ^a   Nedsuwan, Supalert ^f   Sangchun, Wiravoot ^f   Suriyon, Narin ^g   Mitarai, Satoshi ^d   Yamada, Norio ^d  

^a TB/HIV Research Project   (Thailand)

^b JUNTENDO UNIVERSITY   (Japan)

^c Boromrajonani College of Nursing Nakhon Lampang (BCNLP)   (Thailand)

^d RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^e Bureau of Tuberculosis   (Thailand)

^f Chiang Rai Regional Hospital   (Thailand)

^g Chiang Rai Provincial Health Office   (Thailand)

Author keywords

Chiang rai; Drug resistance; MODS assay; Thailand; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC VALUE; FEMALE; GOLD STANDARD; GROWTH RATE; HUMAN; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MICROBIAL SENSITIVITY TEST; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE;

EID: 84861368056     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization (WHO). Global tuberculosis control; 2010. Available from http://www.who.int/tb/publications/global_report/2010/en/index.html. Accessed August 8, 2011.
2. World Health Organization (WHO). Global tuberculosis control; 2011. Available from: http://www.who.int/tb/publications/global_report/en/. Accessed October 24, 2011.
3. World Health Organization (WHO).TB diagnostics and laboratory strengthening; 2011. Available from: http://www.who.int/tb/laboratory/en/. Accessed August 8, 2011.
4. World Health Organization (WHO). Regional Report 2011: Tuberculosis control in Southeast Asain Region; 2011. Available from: http://www.searo.who.int/LinkFiles/TB_Day_Kit_TB_Annual_Report_2011.pdf. Accessed June 8, 2011.
5. Bwanga F, Hoffner S, Haile M, Joloba M. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis. 2009;9:67.
6. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrugresistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42(10):4432-4437.
7. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539-1550.
8. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007;45(4):1093-1097.
9. Michael JS, Daley P, Armstrong L, et al. Prospective evaluation of microscopic observation drug-susceptibility (MODS) assay for the diagnosis of active tuberculosis (TB) in India - preliminary analysis. Int J Infect Dis. 2008;12(Suppl 1):e324.
10. Mello FCQ, Arias MS, Rosales S, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007;45(10):3387-3389.
11. Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008;12(3):332-337.
12. Arias M, Mello FC, Pavón A, et al. Clinical evaluation of the microscopic observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007;44(5):674-680.
13. Limaye K, Kanade S, Nataraj G, Mehta P. Utility of microscopic observation of drug susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuberc. 2010;57(4):207-212.
14. Coronel J, Roper M, Caviedes L, Moore D. MODS. A user guide. Microscopic-observation drug-susceptibility assay; 2008. Available from: http://www.modsperu.org/MODS_user_guide.pdf. Accessed October 12, 2009.
15. Moore DAJ. MODS laboratory accreditation; 2008. http://www.modsperu.org/MODS_laboratory_validation.pdf. Accessed October 12, 2009.
16. Giampaglia CMS, Martins MC, Chimara E, et al. Differentiation of Mycobacterium tuberculosis from other mycobacteria with rho-nitrobenzoic acid using MGIT960. Int J Tuberc Lung Dis. 2007;11(7):803-807.
17. Moore DAJ. MODS QC question from TB HIV research consortium Thailand. In: Aung MN, editor. 2009.
18. Minion J, Leung E, Menzies D, Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(10):688-698.
19. Banerjee Y, Taranikanti V, Bayoumi R. Assays for drug resistant tuberculosis in high burden countries. Lancet Infect Dis. 2011;11(3): 161-162.
20. Palomino JC, Martin A, Portaels F. MODS Assay for the Diagnosis of TB. N Engl J Med. 2007;356(2):188-189.
21. Zimic M, Velazco A, Comina G, et al. Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. PLoS ONE. 2010;5(3):e9577.